3'-Deoxythymidine (3dT) is a weakly active dideoxynucleoside in human immunodeficiency virus (HIV)-infected cells because of its slow phosphorylation by cellular thymidine kinase. 3dT diphosphate dimyristoylglycerol (3dTDP-DMG), a phospholipid prodrug, was synthesized and found in vitro to be 18-to 50-fold more effective than 3dT in CEM and HT4-6C cells. In CEM cells, the selectivity index of 3dTDP-DMG was 270 versus 48 for 3dT, an increase of 5.6-fold. In thymidine kinase-deficient mutant CEM cells infected with HIV, 3dT and zidovudine (AZT) were virtually inactive but 3dTDP-DMG retained substantial activity, suggesting that its greatly increased antiviral activity is due in part to bypass of thymidine kinase. 3dTDP-DMG was 14-to 37-fold more active than 3dT in AZT-sensitive and AZT-resistant clinical isolates of HIV; no cross-resistance with AZT was noted. The results suggest that lipid prodrugs may be utilized in some cases to confer unique metabolic advantages over the corresponding free nucleoside; in the case of 3dTDP-DMG, an 18-to 50-fold increase in antiretroviral activity was observed in LAV-infected cells. The strategy would seem to be especially useful for antiviral nucleosides which are poorly phosphorylated.
0.006 ,uM (1) . In our previous studies with HIV-infected U937 and CEM cells (8) , 3dT was a poor inhibitor of HIV replication, with IC50s of >100 and >32 ,uM, respectively.
As part of our interest in finding compounds which can be targeted to HIV-infected macrophages, we found that phosphatidyl-3dT, a lipid prodrug of 3dT, exhibited increased activity in HIV-infected CEM and U937 cells, compared with that of free 3dT (8) . To further investigate the increased activity exhibited by lipid prodrugs, we synthesized 3dT diphosphate dimyristoylglycerol (3dTDP-DMG). This phospholipid conjugate has an sn-1,2-DMG-3-pyrophosphate group attached to the 5'-hydroxyl of 3dT. This report describes greatly increased biological activity of this com-* Corresponding author. pound versus that of the free nucleoside in both HIVinfected human CEM T lymphoblasts and thymidine kinase (TK)-deficient CEM T-lymphoblast mutants. Possible explanations for the enhanced biological activity of 3dTDP-DMG are proposed.
MATERUILS AND METHODS
Synthesis and purification of 3dTDP-DMG and phosphatidyl-3dT. 3dT (dideoxythymidine) was obtained from Sigma Chemical, St. Louis, Mo. 1,2,-Dimyristoylphosphatidyl-3dT was prepared as reported previously (8) . 3dTMP was prepared by reacting 3dT with phosphorus oxychloride essentially as described previously by Yoshikawa et al. (17, 18) and purified by using a Q-Sepharose column eluted with a gradient of 0.1 M NH4HCO3 (pH 7.2) as described by van Wijk et al. (14, 15) .
3dTDP-DMG was synthesized by a new method which gives higher yields and facilitated purifications; details of the procedure will be reported elsewhere (16) . Briefly, 1,2-dimyristoylphosphatidic acid (Avanti, Birmingham, Ala.) was converted to the morpholidate by reacting it with morpholine in the presence of dicyclohexylcarbodiimide in t-butanol. After removal of the solvents in vacuo, the resulting dimyristoylphosphatic acid morpholidate (5 to 10% molar excess) was allowed to react with 3dTMP (free acid) in dry pyridine for 20 h at room temperature. After (ii) HIV p24 assay. Antiviral activity was measured after 3 days of incubation as the reduction of p24 antigen in the cell-free supematant from the cultured cells which had been exposed to the indicated concentrations of drugs. The p24 antigen was measured in duplicate by enzyme-linked immunosorbent assay (ELISA) (Abbott Laboratories, Chicago, Ill.) according to the manufacturer's instructions. The data are expressed as percentages of the control incubated without drug. Under the conditions of the assay, CEM cells produced viral p24 antigen logarithmically to a peak at 3 days which was roughly 1,000 times greater than residual inoculum levels, with 2.4 to 4 ,ug/ml or greater in culture supernatants.
(iii) HT4-6C cells and plaque reduction assay. CD4-expressing HeLa cells, HT4-6C cells (4), were obtained from Bruce Chesebro, Hamilton, Mont. The effect of antiviral compounds on HIV replication was measured by a plaque reduction assay. Briefly, monolayers of HT4-6C cells were infected with 100 to 300 PFU of virus per well in 24-well microdilution plates. Various concentrations of drug were added to the culture medium, Dulbecco's Modified Eagle Medium containing 5% fetal bovine serum and antibiotics, as noted above. After 3 days at 37°C, the monolayers were fixed with 10% formaldehyde solution in phosphate-buffered saline and stained with 0.25% crystal violet to visualize virus plaques (9) . Antiviral activity was assessed as the percentage of control plaques measured in drug-treated samples.
(iv) Selection of TK-deficient CEM T lymphoblasts. A variant of the human CEM T-lymphoblastoid cell line deficient in hypoxanthine phosphoribosyltransferase was muta- genized by exposure to ethyl methanesulfonate and then grown in 100 nM 5-fluoro-2'-deoxyuridine. Surviving cells were cloned by limiting dilution and assayed for TK activity radiochemically as described previously (13) . RESULTS Antiviral activit in HT4-6C cells. Free 3dT reduced plaque formation by 50% at 90 ,uM in HT4-6C cells infected with HIV-1 (Fig. 1) . However, 3dTDP-DMG caused 50% inhibition at 1.8 ,uM, representing a 50-fold increase in antiviral activity. A lipid control without 3dT liponucleotide had no effect on plaque formation at a lipid concentration equivalent to that of the 100 ,uM liponucleotide samples (a total lipid concentration of 1 mM). The liponucleotide was equally active in liposomal formulation or as the free 3dTDP-DMG in 0.2% DMSO. At 0.1 ,uM, liposomal and DMS0 formulations of 3dTDP-DMG reduced HT4-6C plaque formation relative to untreated HIV-infected controls by 51% + 3% and 53% ± 6%, respectively (n = 3).
Antivriral activity in wild-type CEM T lymphoblasts. The antiviral activities of 3dT and 3dTDP-DMG were assessed in CEM cells infected with HIV-lBRU (Fig. 2) . The lipid prodrug was formulated in liposomes and incubated with HIV-infected CEM cells for 3 days, and the levels of p24 in the supernatant were determined by ELISA. 3dT was a very weak inhibitor of p24 production (IC50, 29 ,uM). 3dTDP-DMG was 18 times more active in HIV-1-infected CEM cells, with 50% inhibition of p24 production noted at 1.6 ,uM.
As noted earlier, phosphatidyl-3dT was three times more effective than free 3dT, with an IC50 of 14 ,uM (8) . A phospholipid liposome control without 3dT liponucleotide and matched for the amount of total lipid per well had no effect on p24 production over a wide range of concentrations, in agreement with our earlier observations (8 of the cell monolayers at liponucleotide concentrations of up to 1,000 ,uM. The selectivity index of 3dTDP-DMG in this cell line is >556.
Characterization of TK-deficient human CEM T lymphoblasts. TK-deficient mutants of CEM T lymphoblasts were selected as noted in Materials and Methods. As determined by radiochemical assay, the fluorodeoxyuridine-resistant CEM mutant had less that 1% of wild-type TK activity in cell extracts. Similarly, viable cells incorporated less than 1% as much [5-3H] thymidine into DNA as did parental cells. These two cell types were used to compare the antiviral activities of 3dT and of the liponucleotides of 3dT.
Activity in HIV-infected TK-deficient CEM mutants. 3dT had little effect on p24 production by HIV-1-infected TK-CEM cells. However, 3dTDP-DMG reproducibly inhibited p24 production by HIV-infected TK-CEM cells, as shown in Fig. 3 . The IC50 of 3dTDP-DMG was about sixfold higher (10.1 ,uM) in the TK-CEM cell line than in the wild-type CEM cells, suggesting that phosphorylation by TK was not required for its antiviral action. The data from TK-cells suggested that the greatly increased activity of 3dTDP-DMG may have been due, at least in part, to its ability to bypass TK because of its unique cellular metabolism. Phosphatidyl3dT was inactive in TK-cells, suggesting that it did not give rise to cellular 3dTMP. (Fig. 3) .
TK-deficient CEM T lymphoblasts infected with HIV were also resistant to AZT; no inhibition of p24 production was observed at AZT concentrations of up to 100 ,uM. However, AZT diphosphate DMG inhibited HIV p24 production by 50% in TK-CEM cells at concentrations of 5 Larder et al. (9) . The data for 3dT and 3dTDP-DMG are the averages of two experiments.
resistant virus isolates first reported by Larder et al. (9) . The AZT-resistant isolates were 200 to 400 times less sensitive to AZT in vitro (9) . 3dT was weakly active in AZT-sensitive clinical isolates, and the resistant isolates did not exhibit any cross-resistance to 3dT ( Table 2 ). 3dTDP-DMG was somewhat less active in the clinical isolates than in the HIV-lBRU laboratory strain of HIV (IC50 of 6 to 20 versus 1.6 ,uM, respectively), but the lipid prodrug of 3dT was 14 to 37 times more active than 3dT in the AZT-sensitive and AZT-resistant clinical isolates. DISCUSSION 3dTDP-DMG is 18 to 50 times more effective than 3dT, in vitro. The precise metabolic reason for the increased activity may be due both to increased cell uptake and to metabolic differences. The studies with TK-deficient CEM T-lymphoblast mutants showed that 3dTDP and AZT diphosphate diglycerides were effective even when cellular TK was essentially absent, suggesting that AZT diphosphate DMG and 3dTDP-DMG can be metabolized directly to AZT monophosphate or 3dTMP, bypassing TK. The exact metabolic explanation for the greatly increased antiviral activity of the liponucleotide diphosphate diglyceride in CEM and HT4-6C cells will require comparative study of cellular levels of the two liponucleotides and their metabolites, including the mono-, di-, and triphosphates of 3dT.
However, in other experiments with membrane fractions isolated from liver, we found that 3dTDP-DMG could substitute for CDP-DG as a substrate for mitochondrial phosphatidylglycerol biosynthesis, providing one possible metabolic explanation for direct formation of 3dTMP (14) . Subsequent experiments showed that the amount of 3dTMP formed was much too large to be accounted for by phosphatidylglycerol synthesis alone. Further study with a 3H-labeled substrate showed direct hydrolysis of 3dTDP-DMG to phosphatidic acid and [3H]3dTMP by a mitochondrial pyrophosphatase (15) .
Although further study in host cells such as CEM, CEM TK-, and HT4-6C and in human monocyte/macrophages is required, it seems likely that 3dTDP-DMG is 18 to 50 times more active than 3dT, at least in part because the liponucleotide can be metabolized directly to 3dTMP, bypassing slow phosphorylation of 3dT by TK. 3dTDP-DMG is also active in AZT-resistant strains of HIV and could be useful clinically in treating HIV infection.
